Skip to main content

Schroder Investment Management Group

Source: SEC Form 13F · as of Mar 2026

Schroder Investment Management Group holds 60 biotech & pharma companies tracked by BioSniper, totaling $682.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

60

Total value held

$682.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.1,585,507$221.0M
TEVATeva Pharmaceutical Industries Limited4,376,270$131.8M
HCMHUTCHMED (China) Limited1,477,494$22.1M
ALNYALNYLAM PHARMACEUTICALS, INC.66,662$22.1M
EXELEXELIXIS, INC.525,533$22.0M
SLNOSOLENO THERAPEUTICS INC648,827$19.8M
INSMINSMED Inc119,958$19.6M
ARGXARGENX SE21,023$14.8M
ONCBeOne Medicines Ltd.49,344$14.0M
AUTLAutolus Therapeutics plc9,489,345$12.1M
RYTMRHYTHM PHARMACEUTICALS, INC.131,674$10.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.162,005$9.3M
REGNREGENERON PHARMACEUTICALS, INC.12,070$9.3M
KALVKalVista Pharmaceuticals, Inc.506,743$9.3M
PTCTPTC THERAPEUTICS, INC.134,968$8.9M
SUPNSUPERNUS PHARMACEUTICALS, INC.176,076$8.7M
BBIOBridgeBio Pharma, Inc.114,884$8.0M
APGEApogee Therapeutics, Inc.96,656$7.6M
RVMDREVOLUTION MEDICINES, INC.64,583$6.0M
TVTXTravere Therapeutics, Inc.214,925$5.9M
VKTXViking Therapeutics, Inc.183,846$5.5M
DNLIDenali Therapeutics Inc.285,820$5.2M
INCYIncyte Corp.53,615$5.0M
SNYSanofi104,189$4.9M
JAZZJazz Pharmaceuticals plc25,077$4.7M
ZVRAZEVRA THERAPEUTICS, INC.506,033$4.4M
PHVSPharvaris N.V.158,019$4.3M
SMMTSummit Therapeutics Inc.251,391$4.3M
TNGXTango Therapeutics, Inc.207,504$4.0M
AXSMAxsome Therapeutics, Inc.23,830$3.8M
IMTXImmatics N.V.402,352$3.7M
BMRNBIOMARIN PHARMACEUTICAL INC56,334$3.2M
IRONDisc Medicine, Inc.50,959$3.1M
SYRESpyre Therapeutics, Inc.63,684$2.9M
ALMSALUMIS INC.137,347$2.8M
BCYCBICYCLE THERAPEUTICS PLC615,833$2.7M
RDYDR REDDYS LABORATORIES LTD181,239$2.4M
CGEMCullinan Therapeutics, Inc.173,740$2.3M
ARDXARDELYX, INC.419,768$2.3M
ARQTArcutis Biotherapeutics, Inc.104,356$2.2M
BBOTBridgeBio Oncology Therapeutics, Inc.249,161$2.2M
SRRKScholar Rock Holding Corp49,942$2.2M
ALTAltimmune, Inc.667,837$1.9M
NUVLNuvalent, Inc.19,844$1.9M
COGTCogent Biosciences, Inc.53,307$1.9M
ABVXAbivax SA17,928$1.8M
CMPSCOMPASS Pathways plc300,000$1.6M
OCULOCULAR THERAPEUTIX, INC188,368$1.4M
ORKAOruka Therapeutics, Inc.29,184$1.3M
IMCRImmunocore Holdings plc42,920$1.3M
CYTKCYTOKINETICS INC18,113$1.1M
STOKStoke Therapeutics, Inc.34,102$1.1M
MAZEMaze Therapeutics, Inc.37,181$1.1M
SVRASavara Inc205,090$1.0M
NGNENeurogene Inc.52,300$1.0M
QUREuniQure N.V.55,015$810K
ZYMEZymeworks Inc.28,349$686K
ZBIOZenas BioPharma, Inc.33,697$614K
ABUSArbutus Biopharma Corp121,313$522K
JBIOJade Biosciences, Inc.39,279$521K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.